iDEM technology

Revolutionary CDMO Set to Transform Stem Cell Therapies!

🌟 Mytos launches automated CDMO for stem-cell therapies! 🔬 Tackling manufacturing challenges, aiming for 1,500 doses annually by 2026! 🚀🌍